Posts

Showing posts from February, 2023

Yes, we have no tomatoes: Why shelves are emptying in UK stores - The Guardian

Image
E arly on Saturday morning, as Paul Crane, a trader at London's renowned Borough market, was arranging blood oranges from Valencia on his stall, he admitted that his industry is facing some of the toughest conditions in a quarter of a century. The wholesale price of tomatoes, peppers and aubergines has quadrupled, and English cauliflowers are up too. Some stallholders are not even selling vine tomatoes because they are just too expensive. "There are supply chain issues, as in there isn't enough to go round. It's all to do with price," said Crane, who has worked in the south London market for more than 35 years. "It's been like it for six or seven weeks. All prices across the board have risen." While supermarkets face problems because growers cannot fulfil their contracts, greengrocers are better placed, said Crane, who had arrived at New Covent Garden Market in Nine Elms, south London, at 3am to buy his stock. As news of fresh goods shortages spread

A retrospective study of pharmacological treatment in anorexia ... - BMC Psychiatry

Image
To our knowledge, this is the first study to retrospectively review BMI courses at five timepoints (at the beginning of treatment and at 3, 6, 9, and 12 months after treatment) in outpatients with AN receiving different medications. In our study, patients who adhered to their antidepressant or antipsychotic medication regimens had a significant BMI increase in the 6-month follow-up, compared with patients who switched medication, used combined medication or did not use medication. These findings suggest that medication adherence to a single medication may play a key role in improving BMI in both the antidepressant and antipsychotic groups. Our study highlights the importance of medication adherence, and the essential role of pharmacotherapy in the treatment of AN. The contributions of this study are further elaborated in the following sections. First, based on the results of our study, it seems that medication adherence is more important than the specific medication in the tre

Stomach Flu Outbreaks Are Rising in the U.S. | HealthNews - Healthnews.com

[unable to retrieve full-text content] Stomach Flu Outbreaks Are Rising in the U.S. | HealthNews    Healthnews.com

FDA Approves New SGLT-2 Inhibitor Brenzavvy - diaTribe Foundation

[unable to retrieve full-text content] FDA Approves New SGLT-2 Inhibitor Brenzavvy    diaTribe Foundation

Medicated eye drops may delay nearsightedness in children - Science News Magazine

Image
An eye drop a day could keep myopia at bay — at least temporarily. Using nightly eye drops with 0.05 percent atropine, a medication that relaxes the eye muscle responsible for focusing vision, may delay myopia onset in children, researchers report February 14 in JAMA . Myopia, also called nearsightedness, is an irreversible condition in which the eyeball grows too long front to back, causing blurred distant vision. It typically begins in childhood, and the earlier it starts, the worse eye health can become later in life. Elongated eyes increase the risk for ocular complications including cataracts, glaucoma and macular degeneration. Science News headlines, in your inbox Headlines and summaries of the latest Science News articles, delivered to your email inbox every Thursday. Thank you for signing up! There was a problem signing you up. The prevalence of myopia has ri

Indapamide - Oral: Uses, Side Effects, Dosages - Verywell Health

Image
What Is Indapamide? Indapamide is an oral prescription drug used to treat hypertension (high blood pressure) alone or in combination with other medicines. It can also treat swelling due to congestive heart failure (CHF). Indapamide is in a drug class called thiazide-like diuretics, often referred to as water pills, because they act directly on the kidneys to promote urine flow. It works by helping the kidneys eliminate excess water and salt in the urine. Indapamide is a generic medication. Its former brand-name product, Lozol, is no longer available. However, you can still get indapamide generically. It is available as a tablet that is taken by mouth. Drug Facts Generic Name : Indapamide Brand Name(s) : Lozol (brand name no longer available) Drug Availability : Prescription Administration Route : Oral Therapeutic Classification : Thiazide-like diuretic Available Generically : Yes Controlled Substance :&

Nurse Pleads Not Guilty to Amputation; Bruce Willis' Dementia; Defy ... - Medpage Today

Image
Note that some links may require subscriptions. A Wisconsin nurse entered a not guilty plea over charges that she amputated a patient's frostbitten foot without consent. ( AP ) Half of kids 5 and under don't eat a daily vegetable and a third don't eat a daily fruit, according to the CDC's 2021 National Survey of Children's Health. ( Morbidity and Mortality Weekly Report ) Black and Hispanic individuals were less likely to be diagnosed with long COVID than whites, but more likely to develop certain post-COVID symptoms like diabetes, dyspnea, headache, and pulmonary embolism, according to findings from the RECOVER program. ( BMC Medicine , Journal of General Internal Medicine ) Moderna's investigational mRNA-based flu vaccine bolstered a strong immune response against A strains in a phase III study, but was less effective than current vaccines against influenza B. Pfizer and Valneva had to pull the plug on their investigational Lyme disease vaccine trial

Generation of a high yield vaccine backbone for influenza B virus in ... - Nature.com

Image
Abstract Influenza B virus (IBV) strains are one of the components of seasonal influenza vaccines in both trivalent and quadrivalent formulations. The vast majority of these vaccines are produced in embryonated chickens' eggs. While optimized backbones for vaccine production in eggs exist and are in use for influenza A viruses, no such backbones exist for IBVs, resulting in unpredictable production yields. To generate an optimal vaccine seed virus backbone, we have compiled a panel of 71 IBV strains from 1940 to present day, representing the known temporal and genetic variability of IBV circulating in humans. This panel contains strains from the B/Victoria/2/87-like lineage, B/Yamagata/16/88-like lineage and the ancestral lineage that preceded their split to provide a diverse set that would help to identify a suitable backbone which can be used in combination with hemagglutinin (HA) and neuraminidase (NA) glycoproteins from any IBV strain to be incorporated into the seasonal vaccin